Editas Medicine (EDIT)

$5.00 0.00 (0.00%)
16:00 EDT EDIT Stock Quote Delayed 30 Minutes
Luke Lango

A Play on the Biggest Scientific Breakthrough of the Century

By Luke Lango, InvestorPlace Senior Investment Analyst
There are only a handful of large, well-established gene editors with robust and mature therapy pipelines in the world today. Of those, one that stands out is a $4.8 billion biotechnology company by the name of Editas Medicine (NASDAQ:EDIT).

7 CRISPR Stocks for the Future of Medicine

Editas Medicine: 6 Things for Potential EDIT Stock Investors to Know Today

5 Disruptive Biotech Stocks to Buy for the Future That Is Here

More Articles
Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 408.16M
PE Ratio -2.40
EPS -2.08
Volume (Avg. Vol.)
Day's Range -
52-Week Range $4.45 - $11.69
Dividend & Yield N/A (N/A)